CanSino’s Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?

The company’s Convidecia has received emergency-use authorization from the World Health Organization, becoming the third Chinese vaccine to get that nod Key Takeaways: CanSino’s Covid-19 vaccine Convidecia will be admitted to the global Covax program following its approval by the WHO The approval could have limited benefits for the company as the pandemic fades and other products are widely available By Jony Ho As the Covid-19 pandemic recedes and countries start to reopen, the World Health Organization (WHO) has just granted an emergency-use license to yet another Chinese vaccine. But…

Read More »

FAST NEWS: Simcere Pharma New Co-CEO Sends Investors Scurrying

The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) announced late Wednesday that executive director Tang Renhong has been appointed as Co-CEO and will assist Chairman and CEO Ren Jinsheng in leading the company’s R&D business. Looking up: Tang has a PhD in molecular cell biology from Nanyang Technological University in Singapore and nearly 12 years of experience working in drug company R&D and management, including tenures at Shanghai Shengdi Pharmaceutical and AstraZeneca Investment (China). His expertise and experience may help to improve the company’s new drug development efforts. Take Note: The…

Read More »

Cash-Rich Ganfeng Lithium Sees Tasty Diversification in Smaller Rare Metals Producer

Miner of the metal used in electric car batteries will buy 16.7% of tantalum and niobium producer Ximei Resources for $31 million Key Takeaways: Ganfeng Lithium will pay HK$240 million for 16.7% of Ximei Resources, a producer of tantalum and niobium. Purchase will diversify Genfeng’s business, and make use of its fat profits built on skyrocketing lithium prices By Andrew Curran Half a decade ago, barely anyone knew what lithium was. Now, the once-exotic metal is enjoying flavor-of-the-month status with a sky-high price to match. The soft, white silvery metal…

Read More »